Tom Frederick
Tom is CEO, Co-founder and Co-Chair of HXSquare, Inc. with over 35 years of experience building, operating, advising and funding entities across a broad spectrum of industries, technologies and solutions, including digital content syndication, data exchange, vertical trading networks, e-commerce, interoperability, digital rights, artificial intelligence, configuration, fintech, workflow and medical devices.
He has collaborated and advised the American Medical Association since 2015 focused on creating and launching the AMA’s innovation ecosystem in roles as Co-Founding Managing Partner of Health2047 Capital Partners Fund I; Board Member of Health2047 Inc; and Co-Founder and Co-Lead of the Integrated Healthcare Model Initiative (IHMI) for improving data exchange, relevance, portability and liquidity in healthcare.
Other relevant positions include CEO at Strategians, CEO at Edgenet (acquired by Syndigo), General Partner at Venrock Associates, Global Head of the Technology and Strategy Consulting at Arthur Andersen Business Consulting, Director on over a dozen public and private boards and various senior executive roles at companies in the data, software and system areas.
Tom holds an MBA from Stanford Graduate School of Business (Arjay Miller Scholar), MS and BS (Bronze Tablet and summa cum laude) from the University of Illinois – Champaign-Urbana, Executive Management Certificate in Strategy from Harvard Business School, and various patents in the healthcare and product information spaces.
HXSquare
HXSquare is a two-sided healthcare data exchange which is capitalizing on the convergence of FinTech and HealthIT. Currently, healthcare data is exchanged in massive volumes but in a fragmented market with immense friction and a lack of trust. This hurts liquidity, efficiency, and the exchange of quality healthcare information. To solve this, HXS has built a negotiated, two-sided, rules-based marketplace for the exchange of healthcare data.
The goal is to enable a liquid, transparent, secure and democratized two-sided market for healthcare data, market intelligence and services that will accelerate drug R&D, clinical trials, distribution, administration and improve patient care.